Key result
Coronary revascularization at the time of aortic valve replacement was performed in approximately 12% of patients in randomized trials and 25% in real-world TAVR registries.
Answers are grounded in this paper and cite their sources.
This commentary highlights the high prevalence of concurrent coronary artery disease and the frequent need for revascularization in patients undergoing aortic valve replacement.
Degenerative aortic stenosis and coronary artery disease (CAD) share similar pathophysiological processes.1 A high proportion of patients with severe aortic stenosis have some degree of CAD, with a prevalence of CAD in transcatheter aortic valve replacement (TAVR) recipients of approximately 50%.2 In randomized trials comparing TAVR and surgical aortic valve replacement (SAVR), coronary revascularization at the time of the replacement operation was performed in approximately 12% of patients (either by percutaneous coronary intervention [PCI] or coronary artery bypass graft [CABG]), and this proportion reached 25% in real-world TAVR registries.
No takes yet. Share an insight, caveat, or question.
Faroux et al. (2020) conducted an editorial in Severe aortic stenosis and coronary artery disease. Coronary revascularization was evaluated. Coronary revascularization at the time of aortic valve replacement was performed in approximately 12% of patients in randomized trials and 25% in real-world TAVR registries.
Synapse has enriched 10 related papers. Consider them for comparative context: